Table 2.
Pre Treatment | Post Treatment | Pre Treatment | Post Treatment | ||||
---|---|---|---|---|---|---|---|
Mean ± SD | Mean ± SD | Frecuency | Valid percent (%) | Frecuency | Valid percent (%) | ||
Tear Meniscus (millimeters) | 0.33 ± 0.14 | 0.38 ± 0.17 | Very high | 26 | 43.3 | 24 | 40 |
Normal | 29 | 48.3 | 30 | 50 | |||
Slightly reduced | 3 | 5 | 5 | 8.3 | |||
Low | 2 | 3,3 | 1 | 1.7 | |||
BUT (seconds) | 13.60 ± 5.01 | 14.95 ± 5.71 | Above average | 28 | 47.46 | 31 | 51.7 |
Normal | 9 | 15.25 | 9 | 15 | |||
Short | 13 | 20.3 | 11 | 18.3 | |||
Very short | 10 | 16.9 | 9 | 15 | |||
Redness (vessels ratio) |
1.48 ± 0.60 | 1.43 ± 0.55 | Normal | 36 | 60 | 37 | 61.7 |
Mild | 20 | 33.3 | 20 | 33.3 | |||
Moderate | 4 | 6.7 | 3 | 5 | |||
Meibography | 1.59 ± 0.67 | 1.40 ± 0.74 | No loss | 1 | 1.7 | 2 | 3.3 |
Less than 33% | 27 | 45.8 | 39 | 65 | |||
Less than 66% | 26 | 44.1 | 12 | 20 | |||
More than 66% | 5 | 8.5 | 7 | 11.7 |
Tear Meniscus, BUT and ocular redness have been described as quantitative outcomes also.